Sequence capture-PCR improves detection of mycobacterial DNA in clinical specimens
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
The rapid identification of mycobacterial DNA in clinical samples by PCR can be useful in the diagnosis of tuberculous infections, but several large studies have found that the sensitivity of this approach is not better than that of culture. In order to improve the sensitivity of detection of mycobacterial DNA in clinical specimens from patients with paucibacillary forms of tuberculosis, we have developed a procedure permitting the specific capture of mycobacterial DNA in crude samples prior to amplification, thereby concentrating the target sequences and removing irrelevant DNA and other potential inhibitors of the amplification reaction (sequence capture-PCR). By using this approach to capture and amplify two different sequences specific for organisms of the Mycobacterium tuberculosis complex (IS6110 and the direct repeat region), it was possible to detect as little as one genome of mycobacterial DNA in samples containing up to 750 micrograms of total DNA, representing a 10- to 100-fold increase in sensitivity compared with that obtained by purifying total DNA prior to amplification. Detection of the IS6110 sequence in pleural fluid samples from patients with tuberculous pleurisy by sequence capture-PCR gave positive results in 13 of 17 cases, including 3 of 3 culture-positive samples and 10 of 14 culture-negative samples. In contrast, when total DNA was purified from these samples by adsorption to a silica matrix prior to amplification, only the three culture-positive samples were positive by PCR. The sensitivity of detection of the direct repeat sequence in these samples by sequence capture-PCR was similar to that of IS6110 and, in addition, permitted immediate typing of the strains from some patients. We conclude that sequence capture-PCR improves the sensitivity of detection of mycobacterial DNA in paucibacillary samples. This approach should be useful in detecting rare target sequences from organisms implicated in other pathologic processes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Eisenach, K. D., Donald Cave, M., Bates, J. H., & Crawford, J. T. (1990) · Journal of Infectious Diseases · doi:10.1093/infdis/161.5.977 · Cited by 748
Cited by
Yang, S., & Rothman, R. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01044-8 · Cited by 1,112
Chakravorty, S., Sen, M. K., & Tyagi, J. S. (2005) · Journal of Clinical Microbiology · doi:10.1128/jcm.43.9.4357-4362.2005 · Cited by 282
“There are numerous examples in the literature of amplification-based test performances being marred by inhibitory substances present in clinical specimens, notably biopsies and proteinaceous pleural effusions which could include blood, host proteins, and even eukaryotic DNA that can inhibit amplification when present…”
BackgroundArmand, S., Vanhuls, P., Delcroix, G., Courcol, R., & Lemaître, N. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.02157-10 · Cited by 179
Honoré-Bouakline, S., Vincensini, J. P., Giacuzzo, V., Lagrange, P. H., & Herrmann, J. L. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2323-2329.2003 · Cited by 168
“In purified DNA preparations, eukaryotic DNA in high amounts ( 1 to 2 g) is the only remaining substance, and this has been shown to have inhibitory properties (34).”
Metadata
- Authors
- Mangiapan, G., Vokurka, M., Schouls, L., Cadranel, J., Lecossier, D., van Embden, J., & Hance, A. J.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 1996-05
- Volume
- 34
- Issue
- 5
- Pages
- 1209-1215
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W2171639169
- Cited by
- 106
- References
- 1
- FWCI
- 6.76
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Sequence capture-PCR improves detection of mycobacterial DNA in clinical specimens. https://app.cochat.ai/papers/10.1128/jcm.34.5.1209-1215.1996
- The paper
- Mangiapan, G., Vokurka, M., Schouls, L., Cadranel, J., Lecossier, D., van Embden, J., & Hance, A. J. (1996). Sequence capture-PCR improves detection of mycobacterial DNA in clinical specimens. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.34.5.1209-1215.1996
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.